Invest in

Biotech Breakthroughs

1.1%
0.3%
1.6%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
1.1%
0.3%
1.6%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
37.4% Cancer 15.3%
20.3% Amgen Inc. AMGN 10.2%
14.8% Celgene Corporation CELG 16.7%
1.3% Seattle Genetics Inc. SGEN 62.6%
1.0% SciClone Pharmaceuticals Inc. SCLN 38.8%
18.5% Other Diseases 14.2%
6.0% Regeneron Pharmaceuticals Inc. REGN 19.9%
5.8% Alexion Pharmaceuticals Inc. ALXN 13.3%
3.6% Vertex Pharmaceuticals Incorporated VRTX 13.7%
2.2% United Therapeutics Corporation UTHR 10.6%
0.9% Acorda Therapeutics Inc. ACOR 44.1%
16.9% Infectious Diseases 16.8%
14.8% Gilead Sciences Inc. GILD 19.2%
1.1% Opko Health Inc. OPK 10.4%
1.1% Emergent Biosolutions Inc. EBS 10.5%
16.8% Autoimmune Disorders 13.7%
9.7% Biogen Inc. BIIB 6.6%
3.3% Incyte Corporation INCY 50.2%
3.0% BioMarin Pharmaceutical Inc. BMRN 3.3%
0.9% Rigel Pharmaceuticals Inc. RIGL 9.4%
10.3% Research & Diagnostics 7.9%
4.1% Illumina Inc. ILMN 1.2%
2.8% Charles River Laboratories International Inc. CRL 8.3%
2.5% Bio-Techne Corp TECH 25.4%
0.9% Meridian Bioscience Inc. VIVO 1.9%

Quotes delayed 15 mins. Currently Jan 17, 2017 4:12:03 PM. Fields are marked with -- when data is unavailable.